Richard Leigh, M.D. Johns Hopkins University School of Medicine.

Slides:



Advertisements
Similar presentations
Preventing Strokes One at a Time Acute Interventions and Management 2009.
Advertisements

Neurology Richard Leigh, MD. Post Partum Headache I  34 y/o healthy woman 3 days post partum after an uncomplicated delivery with epidural anesthesia.
The differential for thunderclap headaches Neurology Resident Teaching Series.
Stroke: Year in Review 2007 South Carolina Society of Health-System Pharmacists Spring Symposium April D. Miller, PharmD South Carolina College of Pharmacy-
Apixaban versus Aspirin in Atrial Fibrillation Patients ≥ 75 years old: An Analysis from the AVERROES Trial Kuan H Ng, Olga O Shestakovska, John W. Eikelboom,
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
Pediatric Stroke Last Updated by Lindsay Pagano Summer 2013.
SPECT imaging in cerebrovascular disease Measurement of regional cerebral blood flow (rCBF) Sensitive indicator of perfusion Diagnosis and prognosis of.
STROKE & PREGNANCY By Judith Barnaby, Stroke CNS Reviewed by Dr. Bayer, Stroke Neurologist, St. Michael’s Hospital.
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
OSLER RENDU WEBER SYNDROME. AIM To diagnose a rare case of OSLER RENDU WEBER SYNDROME Screening methods for first degree relatives of patients for early.
Childhood Stroke Gita V. Massey, MD Coagulation Update 2006 September 30, 2006.
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Embolic Stroke Emily Chang PGY-3 May 4, Definition Particles of debris that originate from another source that lead to blockage of arterial perfusion.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Author(s): Johnston, S Claiborne MD, PhD; Dowd, Christopher F. MD; Higashida, Randall T. MD; Lawton, Michael T. MD; Duckwiler, Gary R. MD; Gress, Daryl.
Cerebral Vein Thrombosis Morning Report Sima Patel 5/13/09.
University of Michigan
Reversible Cerebral Vasoconstriction Syndrome
Transient Ischemic Attack (TIA): The Calm Before the Storm
Thrombo means “clot” and phlebitis is the inflammation of a vein. This occurs when a blood clot causes inflammation in one or more of your veins, specially.
Dr. amal Alkhotani Frcpc neurology, epilepsy
20 Cardiovascular Disease and Physical Activity chapter.
Consultant Neurologist,
Secondary prevention after a TIA or ischemic stroke.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
SPONTANEOUS DISSECTION OF THE CAROTID AND VERTEBRAL ARTERIES N Engl J Med, Vol. 344, No. 12. March 22, 張維傑.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Stroke Association of Southern California Stroke Prevention Stroke Prevention A Guide for Caregivers.
Vertebral Artery Dissection Evaluation and Management William Barsan, M.D. University of Michigan.
Exercise Management Aneurysms Chapter 16. Exercise Management Pathophysiology Aneurysms can be caused by congenital or acquired diseases, are usually.
Extracranial dissection is easily diagnosed by ultrasound.
Peripheral Arterial Disease Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
Acute Stroke: Principles of Modern Management A program of the American Academy of Neurology The AAN Acute Stroke Management courses are supported in part.
The Evolving Management of Pediatric Stroke Christopher A. Miller, MD July 21, 2012.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Morning Report August 7, 2012 Good Morning. Chorea **Show video**
Stroke Damrongsak Bulyalert, M.D., Ph.D.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
UBC-Case 1 Samuel Yip PhD, MD, FRCPC Western Stroke Day 2012.
Long-Term Comparison of Medical Treatment With Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism: A Propensity-Score.
Subarachnoid Hemorrhage Nina T. Gentile, MD Associate Professor Division of Emergency Medicine Temple University School of Medicine Philadelphia, PA.
بسم الله الرحمن الرحيم. POLYCYSTIC KIDNEY DISEASE Lecture by: Dr. Zaidan Jayed Zaidan.
Intracerebral Hemorrhage
Dr. Meg-angela Christi M. Amores
Safety of Cerebral Digital Subtraction Angiography in Pediatric Patients with Sickle Cell Disease. Emily Wyse, BS 1 Jessica Carpenter, MD 2 Suresh Magge,
Rikki Weems, PGY III August 20, 2015
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
KIDNEY & HYPERTENTION 1 Dr. Ruba Nashawati. Kidney Hypertension 2.
Stumper: Too Young for Chest Pain. Stumper A 23 yo man presents to the ED with 4 hours of chest pain –Healthy Denies cigarette smoking, FHx, DM, Hypertension.
Cardioembolic Stroke: Diagnosis and Management
Disclosure Statement of Financial Interest
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.
Cervicocephalic Vascular Occlusion: Thinking Beyond Atherosclerosis Samuel I Frost DO, Yiping Li MD, Beverly Aagaard-Kienitz MD, Tabassum Kennedy.
Venous Thromboembolic Disease: The Role of Novel Anticoagulants Grant M. Greenberg MD, MA, MHSA.
March Ch. 12 p (459 – 512 PULMONARY DISEASES OF VASCULAR ORIGIN.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
ACUTE STROKE Alexa Lauch IMG 310 Summer Semester 2016.
Renal vascular disease
Hypertension In The Stroke Patient
John. J Ricotta, MD, FACS Professor of Surgery, Georgetown University
TUCOM Internal Medicine 4th class
A Case of Recurrent Ischemic Stroke due to Paradoxical Embolism through Different Channels Dong-geun Lee, M.D., Seungyoo Kim, M.D., Jae Young An, M.D.,
Nat. Rev. Neurol. doi: /nrneurol
Strokes.
Etiology of stroke Sanjeeva Onteddu.
Patient Examples of CMR Stress Test in Women Patient #1 is a 70-year-old, post-menopausal woman with typical angina and 3 coronary artery disease (CAD)
Update from education committee
Presentation transcript:

Richard Leigh, M.D. Johns Hopkins University School of Medicine

 Generally stroke in a less than years old  Different from pediatric stroke  Unique causes that are more common in the young  Cervical Artery Dissection  Hypercoagulable States  Vasospasm  Typical causes that are atypical in the young  Hypertension  Diabetes  Hyperlipidemia  Cryptogenic

 Appears to be trending toward younger populations.  This trend appears to be larger in the hemorrhagic stroke population.  Preferentially affecting lower socioeconomic classes.  Attributable to modifiable risk factors: hypertension, obesity and diabetes. ▪ Krishnamurthi et al., Lancet Global Health 2012

 Hart & Miller, Stroke, 1983

 Long-term prognosis for stroke in the young is better than the elderly but higher than the general population  Mostly in the first year after stroke  A bad prognosis is associated with an atherosclerotic risk profile Varona et al., J Neurol, 2004

 Dissection  Cryptogenic with PFO  Reversible vasoconstriction syndrome (RCVS)  Not vasculitis!

 Caused by separation of the arterial wall layers resulting in a false lumen.  A history of trauma is often but not always elicited.  Can be associated with major, minor or trivial trauma  Can be spontaneous or cryptogenic  Typically the dissection occurs at the skull base  Can be diagnosed with CTA, angiogram typically not necessary  Often associated with fibromuscular dysplasia  Rarer conditions also have an increased incidence ▪ Ehlers-Danlos Syndrome Type IV ▪ Marfans Syndrome  Often associated with headache/neck pain acutely and chronically  Responds to migraine therapies  Heparin or ASA are reasonable treatments  With heparin only for 3-6 months then switch to ASA

 Can be detected with CT angiography and MR angiography  Conventional angiography is the gold standard

 Angiography allows for detection of FMD in other vessels  Renal arteries can also be affected

 Prognosis is good  Many dissections are asymptomatic  Recurrent stroke after dissection is rare with treatment  Treat with Aspirin or Coumadin  Avoid anticoagulation of intracranial dissections ▪ LP r/o SAH prior to a/c  Transition to ASA after 3-6 months  Complications  Pseudo aneurysms

 PFO (patent foramen ovale)  20-25% of adults have a PFO  Some times associated with an ASA (atrial septal aneurysm)  PFO can serve as a source of paradoxical embolism  Venous clot (DVT) can traverse a right to left shunt and enter the arterial circulation.  Young people are felt to be at higher risk of paradoxical emboli due to heart chamber pressures that favor a right to left shunt.

 There is an increase incidence of PFO and ASA in patients who have had a cryptogenic stroke.  There is no clear evidence that the PFO itself is the cause of the stroke.  This has lead to many centers advocating not to close PFOs since they are not the cause.  Instead, underlying causes of venous embolism are evaluated and treated. ▪ Hypercoagulable states treated with anticoagulation ▪ Removal of triggers: Birth control, smoking  If no cause if found other than PFO, treat with Aspirin ▪ Recurrent stroke very rare ▪ Data on PFO with ASA conflicting ▪ In the setting of recurrent stroke, PFO is closed

 Primariy CNS Vasculitis?  No! its almost never vasculitis  Systemic rheumatologic diseases should be ruled out  Vasculitis mimicks  Intracranial Athero  RCVS reversible vasoconstriction syndrome  PRES posterior reversible leukoencephelopathy  Cerebral Amyloid Angiopathy  Intravascular lymphoma and other malignancies  Never treat a primary CNS vasculitis without a positive brain biopsy  Image guided biopsy is key

 Frequently misdiagnosed as vasculitis  Vasculitis = smoldering course  Presents with thunderclap HA  Initial w/u is often negative  Patients re-present with ICH/SAH  Can progress to ischemic strokes

Most common trigger at Hopkins: SSRI Ducros et al., Brain 2007

 Does not respond to steroids  Data suggests patients treated with steroids do worse  Treated by removing the trigger  Calcium Channel Blockers  Magnesium  MRA should normalize by 3 months  Re-introduction of the offending agent can cause recurrent RCVS  Continuum?  RCVS Migraine PRES (posterior reversible encephalopathy syndrome)

 Prognosis is good for young stroke survivors  Better recovery  Less recurrent stroke ▪ Identifying the cause is key  Vascular risk factor associated stroke is on the rise in the young  Preventative medicine